Skip directly to search Skip directly to A to Z list Skip directly to navigation Skip directly to site content Skip directly to page options
CDC Home

DSTDP Connect

DSTDP Connect

July 24, 2013

Clinical Trial Results Show Two New Gonorrhea Treatment Combinations

doctor writing prescriptionA recent CDC and National Institutes of Health clinical trial aimed at identifying new gonorrhea treatment options in the face of growing antibiotic resistance proved successful . The trial investigated the efficacy of injectable gentamicin in combination with oral azithromycin, and oral gemifloxacin in combination with oral azithromycin. All of these medications are approved by the U.S. Food and Drug Administration and are available in the United States; however, this is the first clinical trial to evaluate them as combination therapy for gonorrhea.

This clinical trial addresses a DSTDP focus area: antibiotic-resistant gonorrhea. Data show increasing resistance to the antibiotic drugs recommended to treat gonorrhea, so development of new treatment options is crucial. The results of this clinical trial do not change current gonorrhea treatment guidelines. CDC will take the findings of this trial into consideration for inclusion in future treatment guidelines. The study’s principal investigator, DSTDP’s Dr. Robert Kirkcaldy, presented the findings at the meeting of The International Society for Sexually Transmitted Diseases Research in mid-July.


CDC Launches STD Treatment Guidelines App

image of the STD Treatment Guidelines App on three mobile devicesDSTDP recently launched a free STD Treatment Guidelines mobile app for health care providers called STD Tx Guide. Providers who use this app will have quick access to current information about the diagnosis and treatment of 21 STDs and the useful booklet A Guide to Taking a Sexual History. The app is available for Apple and Android devices.

Download the app from the iTunes and Google Play stores or learn more by visiting the STD Tx Guide webpage.


New HPV Study Shows Vaccine Lowering HPV Rates in Teen Girls

photo of four teenage girls using a laptopA new study led by DSTDP’s Dr. Lauri Markowitz and colleagues examined the prevalence of HPV infections in girls and women before and after the introduction of the HPV vaccine. The study, published in the June issue of The Journal of Infectious Diseases, revealed that since the HPV vaccine was introduced in 2006, vaccine-type HPV prevalence has decreased 56 percent among female teenagers 14-19 years of age—a significant reduction. “The decline in vaccine type prevalence is higher than expected and could be due to factors such as herd immunity, high effectiveness with less than a complete three-dose series and/or changes in sexual behavior we could not measure,” said Dr. Markowitz. The promising study results have public health experts and clinicians looking forward to improving HPV vaccine uptake. Additional information on this study can be found in a media release issued by CDC. The conversation about HPV prevention will continue with a Twitter chat hosted by CDC Director Dr. Tom Frieden on Monday, July 29 at 3 PM ET. STD, vaccine, and cancer experts from across the agency will also participate in this Twitter Chat. To join, follow Dr. Frieden on Twitter @DrFriedenCDC and use the hashtag #CDCchat.


Mark Your Calendars: Call for Abstracts – 2014 STD Prevention Conference

STD Prevention Conference logo

The 2014 STD Prevention Conference Scientific Program Committee will begin accepting abstracts for the oral and poster presentations in the areas of STD prevention research, program, and policy on September 2, 2013. Abstracts will be accepted until October 25, 2013.

The Scientific Program for the 2014 STD Prevention Conference is structured to reflect a program science framework -- the new direction of STD prevention in the United States and globally. Please visit the 2014 STD Prevention Conference Call for Abstracts page for additional details about submission requirements, information about late breaker abstracts, and satellite meetings.


New STDP AAPPS Funding Opportunity Announcement Replaces CSPS

illustration of a team meeting with a globe in the background, with FOALast month, DSTDP published a new funding opportunity announcement (FOA) titled Improving Sexually Transmitted Disease Programs through Assessment, Assurance, Policy Development, and Prevention Strategies (STD AAPPS). STD AAPPS will replace the current Comprehensive STD Prevention Systems (CSPS) cooperative agreement which expires at the end of this year. The full text of the FOA, frequently asked questions, and other resources can be found on the STD AAPPS FOA website. If you have questions, please direct them to


Get Ready for the New Health Insurance Marketplace

Need health insurance? New! Get updates about the Health Insurance Marketplace. Learn more.

Beginning October 1, millions of Americans will have a new way to find affordable health coverage--including many free preventive services-- on the new Health Insurance Marketplace.  The Marketplace will offer Americans a whole new way to shop for health insurance to gain greater access to affordable services such as physician visits, preventive care, hospital stays, and prescriptions. Through the same streamlined application process, many will find out if they are eligible for Medicaid or the Children’s Health Insurance Program (CHIP) at the Marketplace.  Community health centers and other organizations will be funded to help consumers navigate the new Marketplace. Consumers can learn more about the Marketplace now and get ready to enroll by visiting or the Spanish-language site or by calling the new 24-hours-a-day consumer call center at 1-800-318-2596. Hearing impaired callers using TTY/TDD technology can call 1-855-889-4325 for assistance.


Upcoming Events for DSTDP

Twitter Chat: Preventing HPV

July 29, 2013 3:00-4:00 pm, ET
More information

Program evaluation, quality improvement, and performance management: Understanding how they relate and their role in public health programs Webinar

August 6, 2013 3:00-4:00 pm, ET
Register here


Contact Us:
  • Centers for Disease Control and Prevention
    1600 Clifton Rd
    Atlanta, GA 30333
  • 800-CDC-INFO
    TTY: (888) 232-6348
  • Contact CDC-INFO The U.S. Government's Official Web PortalDepartment of Health and Human Services
Centers for Disease Control and Prevention   1600 Clifton Road Atlanta, GA 30329-4027, USA
800-CDC-INFO (800-232-4636) TTY: (888) 232-6348 - Contact CDC–INFO
A-Z Index
  1. A
  2. B
  3. C
  4. D
  5. E
  6. F
  7. G
  8. H
  9. I
  10. J
  11. K
  12. L
  13. M
  14. N
  15. O
  16. P
  17. Q
  18. R
  19. S
  20. T
  21. U
  22. V
  23. W
  24. X
  25. Y
  26. Z
  27. #